文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

重症监护室内心脏骤停的流行病学:特征、合并症与心脏骤停后器官衰竭——一项前瞻性观察性研究

Epidemiology of intensive care unit cardiac arrest: Characteristics, comorbidities, and post-cardiac arrest organ failure - A prospective observational study.
PubMed 文献 · Resuscitation · 2020-09-10
一句话结论ICU内发生心脏骤停虽少见(2%),但出院死亡率高达68%,骤停后肝衰竭与SOFA评分是独立死亡预测因素。

该前瞻性观察性研究在一所三级大学医院的12个ICU中连续纳入1年内所有ICU停留期间发生心脏骤停的成人患者,评估发生率、临床与神经结局及器官衰竭与支持情况。7690例患者中176例(2%)发生ICU内心脏骤停,中位年龄70岁,骤停前中位ICU停留3天,初始可除颤心律(室速/室颤)占23%,持续自主循环恢复占80%。骤停后器官衰竭常见:70%出现骤停后心衰,26%新启动肾脏替代治疗,24%发生肝衰竭;ICU出院死亡率66%,医院出院死亡率68%。多因素回归显示骤停后SOFA评分(HR 1.09,95%CI 0.92-3.18;p<0.05)和肝衰竭(HR 2.44,95%CI 1.39-4.26;p<0.001)是死亡的独立预测因素。

要点

  • 7690例ICU患者中176例(2%)发生ICU内心脏骤停,医院出院死亡率68%。
  • 骤停后70%出现心衰、26%新启动肾脏替代治疗、24%发生肝衰竭。
  • 骤停后肝衰竭是独立死亡预测因素(HR 2.44,95%CI 1.39-4.26;p<0.001)。
  • 骤停后SOFA评分是独立死亡预测因素(HR 1.09,95%CI 0.92-3.18;p<0.05)。
  • 初始可除颤心律(室速/室颤)仅占23%,CPR中除颤执行率为19%。

适用人群与场景

  • 一所三级大学医院12个ICU中连续纳入的成人患者,纳入标准为ICU停留期间发生心脏骤停。

研究设计与关键结果

  • 前瞻性观察性研究,为期1年,在12个ICU开展,纳入7690例患者中176例(2%)发生ICU内心脏骤停。
  • 男性占63%,中位年龄70(58-78)岁,骤停前中位ICU停留3(1-8)天。
  • 初始心律为可除颤心律(室速/室颤)者占23%,CPR期间执行除颤者占19%,推测病因为心源性者占24%,持续自主循环恢复占80%。
  • 骤停前57%(n=100)患者处于镇静状态,63%(n=110)接受机械通气,70%需要血管升压药治疗,27%(n=48)需要肾脏替代治疗。
  • 骤停后器官衰竭常见:70%出现骤停后心衰,26%新启动肾脏替代治疗,24%发生肝衰竭。
  • ICU出院死亡率为66%,医院出院死亡率为68%。
  • 多因素回归分析显示,骤停后SOFA评分(HR 1.09,95%CI 0.92-3.18;p<0.05)和肝衰竭(HR 2.44,95%CI 1.39-4.26;p<0.001)是死亡的独立预测因素。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,骤停后肝衰竭发生率和疾病严重程度是死亡的独立预测因素,应纳入后续ICU治疗决策的考量。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Critically ill patients in intensive care units can frequently suffer from cardiac arrest (ICU-CA), the incidence of ICU-CA is associated with high mortality. Most studies on ICU-CA focused on risk factors and intra-arrest determinants. However, there is a lack of data on organ failure after ICU-CA and its clinical implications for outcome. This study aimed to investigate ICU-CA incidence, outcome and the occurrence of organ failure after ICU-CA.

METHODS: We conducted a prospective observational study over a 1-year at 12 intensive care units of a tertiary care university hospital. We included all consecutive adult patients suffering cardiac arrest (CA) during the ICU stay. Incidence, clinical and neurological outcome, as well as organ failure and support were assessed.

RESULTS: Out of 7690 patients, 176 (2%) with ICU-CA were identified during the study period. Male patients comprised 63% and the median age was 70 (58-78) years. The median ICU stay before ICU-CA was 3 (1-8) days. The initial cardiac rhythm was shockable (VT/VF) in 23% of patients; defibrillation during CPR was performed in 19%. The presumed cause of CA was cardiac in 24%, and sustained ROSC was observed in 80% of patients. Before CA 57% (n = 100) of patients were sedated, 63% (n = 110) mechanically ventilated, 70% needed vasopressor therapy and renal replacement therapy was necessary in 27% (n = 48) of patients. Organ failure after ICU-CA was common, 70% suffered from post-CA cardiac failure, renal replacement therapy was newly initiated in 26% of patients and liver failure occurred in 24% of patients. Mortality at ICU-discharge and at hospital discharge was 66 % and 68 %, respectively. Multivariate regression analysis identified the SOFA score [HR 1.09, 95% CI (0.92-3.18); p < 0.05] and liver failure [HR 2.44, 95% CI (1.39-4.26); p < 0.001] after ICU-CA as independent predictors of mortality.

CONCLUSION: The incidence of ICU-CA is rare in critically ill patients. Organ failure before and after ICU-CA is common; liver failure incidence and severity of illness after ICU-CA are independent predictors of mortality and should be considered in further decisions on ICU therapy.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Roedl K, Jarczak D, Blohm R, et al. Epidemiology of intensive care unit cardiac arrest: Characteristics, comorbidities, and post-cardiac arrest organ failure - A prospective observational study. Resuscitation. 2020. PMID: 32920114. doi:10.1016/j.resuscitation.2020.09.003

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。